Amador is a full service CRO that began as a Clin Pharm centric CRO. We decided to grow the business by acquiring regulatory and bioanalytical service capabilities. We are known in the Clin Pharm space very well by the acquisition of A2PG. Meina Liang, formally the global head of AstraZeneca is now our Head of Bioanalytical. We are capable of assisting from the bench to stage IV. If you want to move into translational medicine, and need help in phase 1, we can help you right now with our phase 1 partners. We have partners in Europe as well as the U.S, so we can serve you as a one-stop shop—from preclinical to phase 1/phase II. If you need additional help in phase II & IV we can project manage your work. We have an in-house project management team that can help through all phases of clinical development.